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ABSTRACT
The viscosupplementation and strength training are interventions accepted in the treatment of 
knee osteoarthritis. Objective: The study describes the effect of two interventions in quality of 
life and functional capacity. Method: Thirty women diagnosed with bilateral knee osteoarthritis of 
grade II and III by radiological criteria of Kellgren & Lawrence, were randomized into three groups 
with ten patients each: VSTF group submitted to viscosupplementation and strength training, TF 
group submitted only to strength training and VS group submitted only to viscossuplementation. 
Moments of the study were defined as pre-procedure (PRE), after 48 hours of VS (POS-VS) after 12 
weeks of training (POS T) and after eight weeks of detraining (POS D). Quality of life was assessed 
by the SF-36 BRAZIL, functional capacity by Lequesne index. Intraarticular infiltrations were carried 
out with a single dose of 6 ml / 48 mg with 6,000,000 kDa Hylan GF-20 and strength training 
sessions were held for twelve weeks. Results: Strength training and viscosupplementation were 
effective in the treatment of knee osteoarthritis. Both interventions promoted improvements in 
quality of life and in functional capacity (p ˂  0.001), with advantage to the groups that trained force. 
Conclusion: Strength training is a possible replacement of viscosupplementation in the treatment 
of osteoarthritis of women’s knees. However, the beneficial effect of viscosupplementation in pain 
reduction suggests better efficiency in the strength training execution which may be an advantage 
of the association of both.
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BACKGROUND
Over the years, different became the factors 
that intervene in the transmission and spreading 
of diseases. Such changes happen in developed 
and in developing countries and end up changing 
health promotion and disease prevention 
models, especially when it concerns the elderly 
population, making chronic and degenerative 
diseases, like the Osteoarthritis (OA), take a major 
role in health models, theories and debates.1
Osteoarthritis is currently considered to be a 
clinical syndrome resulting from the unbalance 
between the formation and destruction of 
cartilage, which involves multiple systemic, 
genetic, inflammatory, and mechanical factors 
with  the active participation of the synovia and 
the cartilage of the subchondral bone resulting 
in the so-called joint insufficiency.2-20 which may 
cause alterations in Quality of Life (QL) and in 
Functional Capacity (FC) in patients suffering 
from it, especially those patients  with knee 
osteoarthritis (KOA).21 Pain deprives patients 
from going upstairs and downstairs, kneeling, 
strolling, and associated with morning stiffness 
are the main complaints affecting life style and 
psychosocial characteristics of the patients.21,22 
Although many studies focus on pain and 
on physical incapacity, there has been an 
increasing interest in measuring the effect of 
such diseases on QL, mainly KOA.1,21,22
It is known that the greatest therapeutic 
challenge considering chronic and degenerative 
diseases is behavior change in face of the 
deficiency; chronic pain, incapacity, problem 
solving, and the way patients deal with KOA 
impact negatively their QL.12,21-23 Muscular 
strength reduction is considered a risk factor for 
patients with KOA,24 increased in patients who 
underwent a meniscectomy25 also negatively 
influencing QL, FC and daily activities.24,25
It is fundamental that both FC and QL be 
measured, mainly because it is a commonly 
wrong perception among most patients that 
the symptoms are a natural consequence of 
aging, they consider themselves healthy people 
despite painful joints, unfortunately, such 
misconception is also shared by physicians, 
nurses, physiotherapists, and care-takers.22
Among large joints, the knee joint is the 
most affected, resulting in a functional deficit of 
10% of individuals above 55 years old and in 25% 
of the severe cases of the disease20 reducing QL 
and FC.26-28 Along with that, during senescence, 
the impact occasioned by the debility caused by 
OA, just taking into consideration KOA, is similar 
to those observed in cardiovascular changes.14
There are many pharmacologic and non-
pharmacologic proposals for the treatment of 
KOA. As a pharmacologic proposal, the intra-
articular therapy with HYLAN GF-20 (HGF-20) 
or viscosupplementation (VIS) is recommended 
as clinical management in KOA cases,29 both in 
acute and chronic phases30-32 presenting better 
results when underwent in the initial stages 
of the disease.33-35 The procedure consists in 
improving the joint rheologic condition and the 
viscoelasticity of the synovial fluid.36-38
As a non-pharmacologic proposal, 
aerobic and anaerobic exercise programs are 
recommended when dealing with senescence 
and degenerative diseases, like OA,39-41 and 
recognized as a first-choice consevative 
intervention in KOA treatment, the most 
beneficial being strength training (ST)42,43 
for the improvement brought in physical 
function,44 its analgesic effect,29 and for 
contributing to improve the action of anti-
inflammatory cytokines.45 Exercise is to be 
recommended by physicians only.46
In the last two decades, studies have 
demonstrated a positive relation between regular 
physical exercise practice and the increase of 
longevity, associated with the improvement 
of quality of life and functional capacity.1,12,21-28 
ST in women with KOA controls hypotrophy 
and moderates the progression of the joint 
disease.1,42-44,47-50 However, one cannot find 
studies evaluating the impacts of VIS and ST in 
conjunction, in the FC and in the QL of patients 
with KOA. In this study, it was measured the 
influence of viscosupplementation and strength 
training, in the quality of life and in the functional 
capacity of women with osteoarthritis of the 
knees level II and III.51,52
OBJETIVE
The study describes the effect of two 
interventions in quality of life and functional 
capacity.
METHODS
Study Design
A double-blind, randomized clinical trial.
Subjects
Participants were evaluated at Laboratório 
de Pesquisas Neuromusculares do Instituto 
Nacional de Traumato Ortopedia (PNEURO / 
INTO). Subjects were 30 sedentary women or that 
had spent at least a minimal period of six months 
without any kind of exercising; and assisted at 
the outpatient medical clinic of degenerative 
joint diseases at Serviço de Reumatologia do 
Hospital Universitário Clementino Fraga Filho da 
Universidade Federal do Rio de Janeiro (HUCFF/
UFRJ) with clinic and radiological diagnosis of KOA 
level II and III;51,52 pain complaint equal to or higher 
than 6 according to the Visual Analog Scale – VAS; 
and Body Mass Index - BMI below 39. Patients 
excluded were: the non-collaborative; under age 
of 40; the illiterate or those who answered less 
than 85% of the questions for difficulties due to 
understanding them; with comorbidities that 
would interfere in the development or in the 
execution of the physical exercise program, or that 
might experience cardiovascular risk; with sequel 
to fracture and/or with great angular articular 
deformity, articular blockage, ankylosis eligible 
for surgical procedures; or that had already 
undergone any kind of surgical interventional 
knee treatment; that presented clinical history 
of sensitivity to any kind of chicken protein. 
Dropouts were considered those patients who 
missed more than one evaluation, while those 
missing one evaluation were considered partial 
dropouts.
The study was approved by the CEP 
of HUCFF/UFRJ, under the protocol nº 
41376814.3.0000.5257 in 06/04/2015. Every 
participant filled in and signed an Informed 
Consent Form.
PROCEDURES
Group Formation
Initially, subjects were randomized 
into three groups: group 1 = underwent 
viscosupplementation and strength training 
(VSST); group 2= underwent only strength 
training (ST); group 3= underwent only 
viscosupplementation (VS). The collaborators 
in  the study - the isokinetic evaluator, the 
supervisor of rating scales, and the physical 
educator -were blinded to such randomizations.
Strength Training
ST sessions happened at Centro de 
Treinamento de Força do Centro Ortopédico 
Reumatológico e Fisiátrico (CTF-CORF). Training 
load was prescribed according to the result 
reached in a 10-RM test undertaken until voluntary 
concentric muscular failure was reached, with 
a three-minute interval between series.53,54 
The participants were individually instructed 
about the techniques involved in the execution 
of each exercise. None of the subjects completed 
the 10-RM test; consequently, minimum load 
of equipments was used, leg extension and  leg 
curl, initially to every participant, 5 Kg (PRE), 
worked out slowly and in a controlled manner, 
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three seconds to the concentric phase and 
three seconds to the eccentric phase of the 
movement. ST was undertaken for twelve weeks 
with supervised and monitored sessions by the 
same Physical Education professional obeying 
the following periodization: two series of ten 
repetitions, three times a week using the initial 
load of 5 Kg summing up a volume of 300 Kg a 
week.53 Loads were reevaluated every four weeks 
and weight training volume adjusted individually 
taking into consideration the load achieved by 
each patient (53), up to the completion of twelve 
weeks of training (POS T). After such period of 
time, training was interrupted for eight weeks 
(POST D). The assessments took place in the 
study phases defined as pre-procedure (PRE); 
48hours after the VIS (POS-VS); after 12 twelve 
weeks of training (POS T); and after eight weeks 
of detraining (POS D).
Isokinetic Evaluation
The studies of isokenetic dynamometry of 
the three groups happened at PNEURO/INTO 
in order to determine the maximum extension 
and flexion torques of the knee, in phases PRE, 
POS-VS, POS T, and POS D. To evaluate muscle 
strength an isokinetic dynamometer - CSMI, 
model HUMAC NORM – was used. Subjects 
sat with the lateral femoral condyle aligned 
with the axis of rotation of the machine and 
the ankle attached to the stem component, 
knee attachment was strapped on using velcro. 
To determine maximum voluntary strength, 
isokinetic concentric-concentric knee flexion and 
extension tests within the velocity protocol of 
60º/s in five repetitions were used. The highest 
instant torque found was considered the peak 
torque and used for the analysis.55 Before testing 
procedure, all patients performed warm-up 
exercise in a cycloergometer (5 min., 60 watts).
Viscossuplementation
Intra-articular knee injections using HGF-
20 or VIS were used in all patients. The VSST 
and VS groups were viscosupplemented 
after first isokinetic evaluation while ST was 
viscosupplemented after the conclusion of the 
study. The viscosupplementation injections 
were assisted by ultrasound. The VIS was a single 
dose of 6ml /48 mg with 6.000.000 kDa of HGF-
20 in each knee.56 After infiltrations, patients 
were instructed to rest for a period of 48 hours.57
Instruments and Scales
Generic and specific instruments have 
been used for the assessment of quality of life, 
functional capacity, pain intensity, cardiovascular 
risk, and physical aptitude test. The instruments 
were respectively: BRASIL SF36; Lequesne Index 
for knee osteoarthritis; Visual Analog Scale - VAS; 
Coronary Index Test - RISKO and Physical Activity 
Readiness Questionnarie - PAR-Q,58-62 in PRE, POS 
T and POS D phases, applied by only one examiner. 
Pain was assessed during PRE, POS-VS, POS T, and 
POS D phases, applied by only one examiner.
Statistical Analysis
The data gathered was statistically analyzed 
by the SPSS - Statistical Package for the Social 
Sciences, version 20.0. Analysis of Variance was 
processed by One-way ANOVA and Two-way 
ANOVA for repeated differences within group and 
within moments. It was considered of relevance a 
rate superior to 5% (p < 0,05).
RESULTS
Out of 96 patients eligible for the clinical 
trial, 46 patients did not meet the criteria; 
20 patients were not willing to participate. 
Among the 30 participants included in the 
clinical trial, 20 had osteoarthritis level II and 
10 osteoarthritis level III. There were two 
partial dropouts during detraining (POS D), 
one patient belonging to VSST and another in 
ST for being infected with the ZIKA virus.
The demographic data of subjects presented 
the highest age and BMI averages in the VS group, 
and equivalent levels of KOA severity (50%); 
while the second lowest age and BMI averages 
were, both found in ST group with 80% of least 
severe cases of KOA (n=8). The VSST group had 
the lowest age average among the three groups; 
a higher BMI average in relation to ST, but lower 
than the VS group; and 70% of least severe cases 
of KOA (n=7) (Table 1).
None of the tests undertaken by patients to 
evaluate physical aptitude and cardiovascular 
risk, PAR-Q and RISKO respectively,60-61 excluded 
participants from physical training. All results 
were within normal range in every subject tested.
Both ST and VIS proved to be efficient 
interventions for the treatment of KOA, 
independently of the radiologic disease severity. 
There was reduction in pain; improvement in 
both quality of life and in functional capacity in 
the three groups when comparing values of the 
PRE period to the POS T without reversal of the 
results when compared to POS D (Table 2).
DISCUSSION
Muscle strength reduction of the lower 
limbs has a major impact in everyday activities 
in patients with KOA.1,63 It is known that among 
men and women it is associated with the level 
of pain and the radiological severity of KOA.64 
The results found in this study show benefits of 
the interventions in the three groups of the trial, 
the isokinetic response in PRE-moment is quite 
reduced when compared to the moments POS-
VS, POS T and POS D (Table 2) which demonstrates 
an improvement both in the acute and in the 
long-term response (Table 2).
In the groups that underwent 
viscosupplementation there was a significant 
improvement in the acute isokinetic response, 
in both flexor and extensor muscle groups, 
with differences in peak torque at POS-VS 
moment when compared to PRE-moment 
(Table 2). Analyzing PÓS T and PÓS D moments, 
it is noticeable that even without training the 
results suggest a relation with isokinetic load 
and the improvement in quality of life and in 
functional capacity (Table 2), which has already 
been demonstrated by Miltner et al.65 and by 
Diracoglu et al.66
The groups that underwent strength 
training show significant differences in the 
flexion and extension peak torques in relation 
to PRE-moment (p < 0,05), with equivalence in 
extension isokinetic response between VSST and 
ST groups in POS T moment and a better result, 
in the same moment, in the flexion isokinetic 
response in group VSST, with equivalent gain 
maintenance by both groups in POS D moment, 
both in extensor and flexor torques (Table 2).
Viscosupplementa-
tion + Training (n=10) Training (n=10)
Viscosupplementa-
tion (n=10) p-value
Age (years) 61,90 ± 7,23 64,00 ± 8,82 67,80 ± 9,31 NA
Height (cm) 160,70 ± 6,55 159,60 ± 6,90 157,00 ± 3,94 NA
Body Weight (kg) 78,42 ± 11,93 74,72 ± 13,7 82,43 ± 10,23 NA
BMI (kg/m2) 30,41 ± 4,68 29,58 ± 4,00 33,45 ± 4,12 NA
Osteoarthritis L II 7 8 5 NA
Osteoarthritis L III 3 2 5 NA
NA = not applicable
Table 1. Demographic and clinical characteristics of participants in different intervention 
study groups
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Concerning the intervention effects in the 
pain reported by patients, it is observed that 
the acute response of viscosupplementation, 
between PRE and POS-VS moments, assessed 
by VAS presents meaningful difference (p < 
0,001) proving that viscosupplementation is 
very efficient in immediate pain reduction. 
In the same way, the long-term response was 
also satisfactory since its analgesic effect was 
significantly different from POST and POSD 
moments (p < 0,001) in viscosuplemented 
groups (Table 2) corroborating with the results 
found in a great number of prior studies that 
evaluated the pain reported by patients who 
underwent viscosupplementation.21,29,31-38,67-71
On the other hand, strength training 
improved the pain relief referred by patients 
in trained groups (p < 0,001), with discrete 
advantage to VSST group over ST group; with 
maintenance of obtained benefits, but inferior 
to the maintenance observed in groups that 
underwent viscosupplementation (Table 2). 
Such advantage might be explained, by the 
reduction in pain severity directly promoted 
by viscosupplementation thus providing better 
joint mechanic efficiency, better reologic effect, 
and consequently suggesting a better response 
in training considering that in the 4th week there 
was a percentage equivalence in the evolution of 
training load between both groups, while in the 
8th week of training, the VSST group presented 
a higher evolutionary percentage than the ST 
group (Table 3). This result, suggests an earliest 
closure of motor engram, that according to 
Moritani et al.71 normally happens after five 
weeks of training.
Few studies assessed the effect of such 
interventions in quality of life and in functional 
capacity, among these few, it is worth 
highlighting the study by Rat et al.21 in patients 
with KOA level II and III treated with HGF-20 
and evaluated in three moments: pre , after 
3 months and after 6 months of intervention 
showing improvements assessed within 
moments in the quality of life by SF36, in pain 
severity by VAS, and in functional capacity 
by Lequesne index, but without considering 
interactions with other interventions.
Our results also show benefits in quality of 
life, with considerable difference in the scores 
assessed by SF-36, higher than ten in global scores 
and in other domain scores, in comparison from 
PRE to POS T and POS D (p < 0,001) in the three 
groups, in all interventions, with an advantage to 
the groups that underwent viscosupplementation 
PRE POS VS POS T POS D P-value
Extension Isokinetic Response (average ± DP) Peak Torque (Nm. kg-1)
VSST+ VS 0,92 ± 0,33 0,96 ± 0,33 NA NA 0,367*
VSST 1,08 ± 0,38 NA 1,17 ± 0,44 1,14 ± 0,40 p < 0,05**
SP 1,05 ± 0,24 NA 1,16 ± 0,23 1,14 ± 0,15 p < 0,05**
VS** 0,76 ± 0,16 NA 0,77 ± 0,12 0,73 ± 0,14 NA
Flexion Isokinetic Response (average ± DP) Peak Torque (Nm. kg-1)
VSST/VS 0,60 ± 0,23 0,66 ± 0,23 NA NA 0,125*
VSST 0,71 ± 0,28 NA 0,81 ± 0,29 0,79 ± 0,26 p < 0,05**
ST 0,69 ± 0,13 NA 0,73 ± 0,19 0,78 ± 0,15 p < 0,05**
VS** 0,50 ± 0,11 NA 0,57 ± 0,14 0,53 ± 0,16 NA
VAS (average ± DP)
VSST + VS 7,45 ± 1,19 3,80 ± 0,83 NA NA < 0,001
VSST 7,1 ± 0,88 NA 1,8 ± 0,79 1,9 ± 0,88 < 0,001
ST 6,5 ± 0,71 NA 2,0 ± 1,25 2,4 ± 1,43 < 0,001
VS 7,8 ± 1,40 NA 1,5 ± 1,18 1,60 ± 1,26 < 0,001
BRASIL SF-36 (average ± DP) SCORE
VSST 99,9 ± 21,2 NA 122,6 ± 9,3 124,3 ± 9,3 < 0,001
ST 95,4 ± 18,9 NA 117,7 ± 12,3 121,2 ± 15,5 < 0,001
VS 98,2 ± 24,9 NA 126,0 ± 14,3 127,9 ± 13,9 < 0,001
HEALTH
VSST 60,2 ± 22,5 NA 77,6 ± 18,1 77,9 ± 18,6 < 0,001
ST 62,8 ± 17,6 NA 75,0 ± 13,0 76,0 ± 14,3 < 0,001
VS 62,6 ± 20,2 NA 83,6 ± 15,7 85,8 ± 13,2 < 0,001
FUNCTIONAL CAPACITY
VSST 49,1 ± 39,7 NA 78,0 ± 20,7 83,0 ± 17,7 < 0,001
ST 46,5 ± 29,2 NA 77,5 ± 13,6 81,0 ± 15,1 < 0,001
VS 48,5 ± 23,0 NA 77,0 ± 19,5 85,5 ± 11,9 < 0,001
PHYSICAL LIMITATION
VSST 40,0 ± 47,4 NA 97,5 ± 7,9 97,5 ± 7,9 < 0,001
ST 40,0 ± 35,7 NA 100,0 ± 0,0 100,0 ± 0,0 < 0,001
VS 55,0 ± 43,8 NA 97,5 ± 7,9 100,0 ± 0,0 < 0,001
EMOTIONAL LIMITATION
VSST 53,3 ± 50,2 NA 100,0 ± 0,0 100,0 ± 0,0 < 0,001
ST 43,3 ± 41,7 NA 96,7 ± 10,6 96,7 ± 10,6 < 0,001
VS 66,7 ± 41,6 NA 92,5 ± 23,7 100,0 ± 0,0 < 0,001
SOCIAL ASPECT
VSST 49,6 ± 39,7 NA 88,8 ± 10,9 90,0 ± 9,9 < 0,001
ST 57,9 ± 25,2 NA 83,8 ± 16,7 86,3 ± 17,1 < 0,001
VS 75,8 ± 32,5 NA 95,3 ± 6,2 95,0 ± 6,5 < 0,001
PAIN
VSST 45,9 ± 20,9 NA 73,9 ± 15,5 80,9 ± 14,7 < 0,001
ST 35,7 ± 15,5 NA 73,8 ± 9,9 74,0 ± 9,2 < 0,001
VS 50,7 ± 23,4 NA 84,4 ± 9,9 85,8 ± 13,4 < 0,001
VITALITY
VSST 63,5 ± 23,5 NA 82,5 ± 15,1 82,5 ± 15,9 < 0,001
ST 54,0 ± 22,5 NA 70,5 ± 16,4 68,5 ± 14,9 < 0,001
VS 52,0 ± 28,2 NA 82,0 ± 16,4 76,5 ± 19,7 < 0,001
MENTAL HEALTH
VSST 70,0 ± 19,0 NA 78,0 ± 17,0 80,4 ± 13,3 < 0,001
ST 62,4 ± 20,1 NA 70,0 ± 19,1 70,4 ± 18,1 < 0,001
VS 62,8 ± 26,4 NA 82,2 ± 17,8 82,0 ± 23,0 < 0,001
LESQUESNE (average ± DP)
VSST 9,65 ± 2,5 NA 5,9 ± 1,3 1,75 ± 1,9 < 0,001
ST 9,15 ± 2,1 NA 2,25 ± 2,3 1,39 ± 1,3 < 0,001
VS 11,1 ± 3,4 NA 2,45 ± 1,5 2,2 ± 1,4 < 0,001
Table 2. Outcome
NA – Not Applicable, ** Significantly Different Over VS, * Without Significant Difference.
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(Table 2). The social aspect domain shows that VS 
group was significantly different from VSST and 
ST groups (p < 0,05) and among PRE, POS T and 
POS D moments (p < 0,001), however it was not 
identified the reason for such difference and we 
attributed it to the initial value shown by the VS 
group because when it was summed to the other 
moments it resulted in a higher value than those 
in the other groups (Table 2).
The domain pain shows a difference between 
ST and VS groups (p < 0,001) and among PRE 
moment in comparison to POS T and POS D (p 
< 0,001), therefore the same result in the VAS 
assessment, which was previously discussed 
(Table 2). These results are also compatible 
to Vincent et al.72 studies, that evaluated pain 
and functional capacity in patients with KOA 
level II that underwent viscosupplementation 
concluding that it reduces pain intensity, but 
showing a discrete impact on the functional tests 
results; this finding may be explained by the lack 
of strength training. In this study, the domain 
functional capacity in the VSST group presents a 
better score in POS T moment while the VS group 
in POS D moment (Table 2), possibly exposing the 
direct detraining influence in functional capacity, 
still, the group without training did not refer or was 
not able to notice differences in the improvement 
obtained after viscosupplementation in their 
everyday activities.
These findings were also reproduced by 
Lequesne functional index for KOA, showing 
a sensible reduction in the sample average 
in the three groups in the comparison of the 
moments being significantly different from 
POS T and POS D moments (p < 0,001), with 
advantage to the groups that underwent 
strength training (Table 2).
In the present study, the efficiency of 
both interventions was confirmed in isolation 
or in association. Both strength training and 
viscosupplementation are efficient in KOA 
treatment, independently of its severity 
level. There was a reduction in pain severity, 
improvement in quality of life, in functional 
capacity, and in the isokinetic response, in every 
moment and with lasting effect. On the other 
hand, the hypothesis that the association of 
interventions would be more efficient than the 
use of one of them alone was not confirmed. 
However, it was shown that strength training, 
for its known beneficial effect in the joint 
mechanic24-28,42-44,47-50 and anti inflammatory 
action45 was, in isolation or in association, 
superior to viscosupplementation isolated 
suggesting a positive effect in the isokinetic 
response, reducing pain severity, and improving 
quality of life and functional capacity.
CONCLUSION
In conclusion, it is suggested strength training 
as a possible alternative to viscosupplementation 
in the treatment of KOA in women, since it is a 
lower cost alternative to viscosupplementation 
and for showing benefits in pain management, 
quality of life, functional capacity, and in the 
isokinetic response. However, the beneficial 
effect of viscosupplementation in pain reduction 
suggests better efficiency in the strength 
training execution which may be an advantage 
of the association of both. Later studies may 
demonstrate the possibility of generalization of 
such recommendations.
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